









Markets
/
Stocks
/
nasdaq-dawn
/

Day One Biopharmaceuticals Inc

DAWN

7.210USD

+0.220+3.15%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

738.53MMarket Cap

LossP/E TTM



Day One Biopharmaceuticals Inc

7.210

+0.220+3.15%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

313.92%33.91M

--30.76M

--29.21M

--93.76M

--8.19M

----

Revenue

313.92%33.91M

--30.76M

--29.21M

--93.76M

--8.19M

----

Cost of revenue

432.53%3.77M

--2.88M

--2.98M

--1.59M

--707.00K

----

Operating expenses

-44.00%68.88M

7.58%71.83M

58.85%94.54M

24.66%64.13M

149.72%123.00M

45.60%66.77M

39.24%59.52M

29.57%51.44M

34.14%49.25M

65.26%45.85M

94.51%42.74M

106.33%39.70M

137.83%36.72M

72.50%27.75M

--21.98M

440.33%19.24M

568.64%15.44M

809.33%16.09M

--3.56M

--2.31M

--1.77M

R&D expenses

-60.75%36.15M

-1.47%39.62M

65.53%61.82M

1.21%33.56M

186.20%92.11M

44.49%40.21M

43.54%37.35M

50.50%33.16M

42.65%32.18M

85.48%27.83M

132.55%26.02M

123.73%22.04M

127.56%22.56M

18.77%15.00M

--11.19M

288.21%9.85M

589.91%9.91M

1214.46%12.63M

--2.54M

--1.44M

--961.00K

Depreciation, depletion, and amortization

136.27%964.00K

670.69%894.00K

636.89%759.00K

653.54%746.00K

343.48%408.00K

30.34%116.00K

-42.78%103.00K

-40.00%99.00K

-30.83%92.00K

67.92%89.00K

252.94%180.00K

230.00%165.00K

171.43%133.00K

8.16%53.00K

--51.00K

8.70%50.00K

6.52%49.00K

--49.00K

--46.00K

----

Operating profit

69.54%-34.97M

38.49%-41.07M

-9.77%-65.33M

157.61%29.64M

-133.09%-114.81M

-45.60%-66.77M

-39.24%-59.52M

-29.57%-51.44M

-34.14%-49.25M

-65.26%-45.85M

-94.51%-42.74M

-106.33%-39.70M

-137.83%-36.72M

-72.50%-27.75M

---21.98M

-440.33%-19.24M

-568.64%-15.44M

-809.33%-16.09M

---3.56M

---2.31M

---1.77M

Net non-operating interest income (expenses)

Non-operating interest expense

----

-33.33%6.00K

-30.00%7.00K

133.33%7.00K

--9.00K

--10.00K

--3.00K

Gains from sale of securities

17.90%4.67M

16.70%5.09M

20.46%6.05M

0.59%5.32M

--3.96M

25.94%4.37M

--5.02M

--5.29M

----

--3.47M

----

Special income (expenses)

-100.00%0.00

----

--0.00

--108.00M

----

Other non-operating income (expenses)

-90.00%-19.00K

-130.00%-23.00K

322.22%40.00K

40000.00%1.20M

33.33%-10.00K

-150.00%-10.00K

30.77%-18.00K

-133.33%-3.00K

---15.00K

-300.00%-4.00K

-285.71%-26.00K

28.57%9.00K

100.00%0.00

87.50%-1.00K

--14.00K

102.57%7.00K

70.00%-27.00K

96.36%-8.00K

---272.00K

---90.00K

---220.00K

Income before tax

-962.07%-30.32M

42.33%-36.00M

-8.68%-59.24M

178.34%36.16M

93.77%-2.85M

-47.22%-62.41M

-35.91%-54.51M

-22.11%-46.15M

-25.55%-45.86M

-52.78%-42.39M

-82.83%-40.11M

-96.44%-37.80M

-136.09%-36.53M

-72.33%-27.75M

---21.94M

-400.78%-19.24M

-542.30%-15.47M

-708.28%-16.10M

---3.84M

---2.41M

---1.99M

Income tax

-100.00%0.00

--0.00

--6.47M

---882.00K

--1.55M

----

Income after tax

-588.04%-30.32M

42.33%-36.00M

-20.55%-65.71M

180.25%37.04M

90.39%-4.41M

-47.22%-62.41M

-35.91%-54.51M

-22.11%-46.15M

-25.55%-45.86M

-52.78%-42.39M

-82.83%-40.11M

-96.44%-37.80M

-136.09%-36.53M

-72.33%-27.75M

---21.94M

-400.78%-19.24M

-542.30%-15.47M

-708.28%-16.10M

---3.84M

---2.41M

---1.99M

Net income from continuous operations

-588.04%-30.32M

42.33%-36.00M

-20.55%-65.71M

180.25%37.04M

90.39%-4.41M

-47.22%-62.41M

-35.91%-54.51M

-22.11%-46.15M

-25.55%-45.86M

-52.78%-42.39M

-82.83%-40.11M

-96.44%-37.80M

-136.09%-36.53M

-72.33%-27.75M

---21.94M

-400.78%-19.24M

-542.30%-15.47M

-708.28%-16.10M

---3.84M

---2.41M

---1.99M

Net Income attributable to non-controlling interests

----

--0.00

----

--0.00

-100.00%0.00

100.00%0.00

--0.00

100.00%0.00

15323.88%98.80M

-101.09%-919.00K

---1.02M

---649.00K

---457.00K

Net income attributable to controlling interests

-588.04%-30.32M

42.33%-36.00M

-20.55%-65.71M

180.25%37.04M

90.39%-4.41M

-47.22%-62.41M

-35.91%-54.51M

-22.11%-46.15M

-25.55%-45.86M

-52.78%-42.39M

-82.83%-40.11M

-96.44%-37.80M

68.03%-36.53M

-82.76%-27.75M

---21.94M

-581.30%-19.24M

-6392.95%-114.28M

-889.06%-15.18M

---2.82M

---1.76M

---1.54M

Net income attributable to common shareholders

-588.04%-30.32M

42.33%-36.00M

-20.55%-65.71M

180.25%37.04M

90.39%-4.41M

-47.22%-62.41M

-35.91%-54.51M

-22.11%-46.15M

-25.55%-45.86M

-52.78%-42.39M

-82.83%-40.11M

-96.44%-37.80M

68.03%-36.53M

-82.76%-27.75M

---21.94M

-581.30%-19.24M

-6392.95%-114.28M

-889.06%-15.18M

---2.82M

---1.76M

---1.54M

Basic earnings per share

-481.63%-0.29

51.33%-0.35

-1.25%-0.64

171.39%0.38

91.73%-0.05

-22.24%-0.72

-12.62%-0.63

-0.88%-0.54

-1.76%-0.61

-23.93%-0.59

-58.86%-0.56

-59.11%-0.53

67.42%-0.60

-88.88%-0.48

---0.35

-614.81%-0.33

-6225.95%-1.85

-889.07%-0.25

---0.05

---0.03

Diluted earnings per share

-481.63%-0.29

51.33%-0.35

-1.25%-0.64

171.16%0.38

91.73%-0.05

-22.24%-0.72

-12.62%-0.63

-0.88%-0.54

-1.76%-0.61

-23.93%-0.59

-58.86%-0.56

-59.11%-0.53

67.42%-0.60

-88.88%-0.48

---0.35

-614.81%-0.33

-6225.95%-1.85

-889.07%-0.25

---0.05

---0.03

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

